Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: Report of three cases

Aging - Clinical and Experimental Research

Volumn 24, Issue 3, 2012, Pages 273-277

  Sciascia, Savino ^a   Piras, Doloretta ^b   Baldovino, Simone ^a   Russo, Alessandra ^a   Naretto, Carla ^a   Rossi, Daniela ^a   Alpa, Mirella ^a   Roccatello, Dario ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b BROTZU HOSPITAL   (Italy)

Author keywords

Giant cell arteritis; Mycophenolate mofetil; Steroid sparing agent

Indexed keywords

ALENDRONIC ACID; AMLODIPINE; HYDROCHLOROTHIAZIDE; METFORMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAMIPRIL;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FOLLOW UP; GERIATRIC PATIENT; GIANT CELL ARTERITIS; HEADACHE; HUMAN; HYPERTENSION; INFLAMMATION; JAW CLAUDICATION; JAW DISEASE; MALE; OBESITY; OSTEOPOROSIS; TREATMENT RESPONSE;

EID: 84868642972     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/BF03325257     Document Type: Article

References (16)

1. Hunder GG. Textbook of Rheumatology: Giant cell arteritis and polymyalgia rheumatica, 5th ed. Philadelphia: WB Saunders, 1996: 898.
2. Evans JM, Bowles CA, Bjornsson J, Mullany CJ, Hunder GG. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994; 37: 1539-47. (Pubitemid 24337700)
3. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83: 806-12.
4. Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Guitierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001; 134: 106-14. (Pubitemid 32096337)
5. Hoffman GS, Cid MC, Hellmann DB et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002; 46: 1309-18. (Pubitemid 34525840)
6. Spiera RF, Mitnick HJ, Kupersmith M et al. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001; 19: 495-501. (Pubitemid 32894598)
7. Bédane C, Doffoel Hantz V. Mucous membrane pemphigoid: a review. Ann Dermatol Venereol 2011; 138: 201-8.
8. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8. (Pubitemid 20273297)
9. Dasgupta B, Borg FA, Hassan N et al. BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 2010; 49: 1594-7.
10. Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med 1975; 82: 613-8.
11. Myles AB, Perera T, Ridley MG. Prevention of blindness in giant cell arteritis by corticosteroid treatment. Br J Rheumatol 1992; 31: 103-5.
12. Salvarani C, Macchioni PL, Tartoni PL et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987; 5: 205-15. (Pubitemid 18037233)
13. Lundberg I, Hedfors E. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1990; 17: 1340-5. (Pubitemid 20382862)
14. Mahr AD, Jover JA, Spiera RF et al. Adjunctive methotrexate to treat giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2006; 56: 2789-97. (Pubitemid 47237299)
15. Pipitone N, Salvarani C. Improving therapeutic options for patients with giant cell arteritis. Curr Opin Rheumatol 2008; 20: 17-22. (Pubitemid 351339427)
16. Daina E, Schieppati A, Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med 1999; 130: 422-6. (Pubitemid 29111224)